These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 3033039)

  • 21. Accumulation of adenosine cyclic 3',5'-monophosphate in rat cerebral cortical slices. Stimulatory effect of alpha and beta adrenergic agents after treatment with 6-hydroxydopamine, 2,3,5-trihydroxyphenethylamine, and dihydroxytryptamines.
    Huang M; Ho AK; Daly JW
    Mol Pharmacol; 1973 Nov; 9(6):711-7. PubMed ID: 4148652
    [No Abstract]   [Full Text] [Related]  

  • 22. Serotonergic modulation of persistent sodium currents and membrane excitability via cyclic AMP-protein kinase A cascade in mesencephalic V neurons.
    Tanaka S; Chandler SH
    J Neurosci Res; 2006 May; 83(7):1362-72. PubMed ID: 16557576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the adrenergic receptors mediating a rise in cyclic 3'-5'-adenosine monophosphate in rat cerebral cortex.
    Perkins JP; Moore MM
    J Pharmacol Exp Ther; 1973 May; 185(2):371-8. PubMed ID: 4350039
    [No Abstract]   [Full Text] [Related]  

  • 24. Lack of effect of erythropoietin on cyclic adenosine-3',5'-monophosphate levels in rat fetal liver cells.
    Graber SE; Carrillo M; Krantz SB
    J Lab Clin Med; 1974 Feb; 83(2):288-95. PubMed ID: 4359408
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparative effect of physiological levels of leptin and insulin on cyclic AMP-induced stimulation of hepatic glycogen breakdown.
    Vardanega-Peicher M; Curi R; Souza HM; Borba-Murad GR; Siqueira VL; Galende S; Bazotte RB
    Pol J Pharmacol; 2003; 55(4):659-62. PubMed ID: 14581728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Intractable diseases and experimental models].
    Okuni H
    Nihon Ika Daigaku Zasshi; 1983 Apr; 50(2):282-4. PubMed ID: 6863493
    [No Abstract]   [Full Text] [Related]  

  • 27. Oxidative stress in neurological diseases: cause or effect?
    Díaz-Hung ML; González Fraguela ME
    Neurologia; 2014 Oct; 29(8):451-2. PubMed ID: 24139387
    [No Abstract]   [Full Text] [Related]  

  • 28. [Statement of the possible role of adenyl cyclase system and cyclic adenosine monophosphate in the carcinogenesis process].
    Jedrzejczak W
    Przegl Lek; 1973; 30(3):316-20. PubMed ID: 4349076
    [No Abstract]   [Full Text] [Related]  

  • 29. [Changes in the cyclic adenosine monophosphate content of rat tissues in a neurodystrophic process].
    Azhipa IaI; Egorova LK
    Izv Akad Nauk SSSR Biol; 1982; (3):389-97. PubMed ID: 6284826
    [No Abstract]   [Full Text] [Related]  

  • 30. [Serotonin content and 5-hydroxytryptophan decarboxylase activity in the tissues of rats with trophic impairment of the nervous system].
    Azhipa IaI; Egorova LK
    Izv Akad Nauk SSSR Biol; 1987; (1):96-103. PubMed ID: 3493278
    [No Abstract]   [Full Text] [Related]  

  • 31. [Changes in the serotonin metabolism of rats with neurodystrophic process].
    Egorova LK; Azhipa IaI
    Vopr Med Khim; 1986; 32(2):25-8. PubMed ID: 3010567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effect of different body allowances of aldosterone on serotonin and cAMP metabolism in the tissues of rats with a disordered trophic function of the nervous system].
    Azhipa IaI; Egorova LK
    Izv Akad Nauk Ser Biol; 1992; (3):417-32. PubMed ID: 1339012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of the beta adrenergic receptor in the elevation of adenosine cyclic 3',5'-monophosphate and induction of serotonin N-acetyltransferase in rat pineal glands.
    Deguchi T
    Mol Pharmacol; 1973 Mar; 9(2):184-90. PubMed ID: 4145804
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cyclic adenosine-3',5'-monophosphate and serotonin in the tissues of rats at various stages of a neurodystrophic process].
    Azipa IaI; Egorova LK
    Izv Akad Nauk SSSR Biol; 1987; (2):185-95. PubMed ID: 3033039
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.